Overview
Norifumi Shioda practices in Kumamoto, Japan. Shioda is rated as an Advanced expert by MediFind in the treatment of Fragile X Syndrome. Their top areas of expertise are Alpha Thalassemia X-Linked Intellectual Disability Syndrome, Alpha Thalassemia, Fragile X Syndrome, and Thalassemia.
Their clinical research consists of co-authoring 63 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 4 articles in the study of Fragile X Syndrome.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Alpha Thalassemia X-Linked Intellectual Disability Syndrome
- Advanced
- Alpha ThalassemiaShioda isAdvanced. Learn about Alpha Thalassemia.
- Fragile X SyndromeShioda isAdvanced. Learn about Fragile X Syndrome.
- Experienced
- Alzheimer's DiseaseShioda isExperienced. Learn about Alzheimer's Disease.
- AnemiaShioda isExperienced. Learn about Anemia.
- Congenital Hemolytic AnemiaShioda isExperienced. Learn about Congenital Hemolytic Anemia.
- Corticobasal DegenerationShioda isExperienced. Learn about Corticobasal Degeneration.
- DementiaShioda isExperienced. Learn about Dementia.
- Drug Induced DyskinesiaShioda isExperienced. Learn about Drug Induced Dyskinesia.